SEVERANCE AND CHANGE IN CONTROL AGREEMENTSeverance and Change in Control Agreement • May 7th, 2015 • Aveo Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
THIS SEVERANCE AND CHANGE IN CONTROL AGREEMENT (the “Agreement”), made this 9th day of January 2015 (the “Effective Date”), is entered into by AVEO Pharmaceuticals, Inc., a Delaware corporation with its principal place of business at 650 East Kendall Street, Cambridge, MA 02142 (the “Company”), and Michael N. Needle, M.D. (the “Employee”).
Amendment No. 1 to At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • May 7th, 2015 • Aveo Pharmaceuticals Inc • Pharmaceutical preparations • New York
TRANSITION AND SEPARATION AGREEMENTTransition and Separation Agreement • May 7th, 2015 • Aveo Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
This Transition and Separation Agreement, dated as of January 6, 2015 (the “Agreement”), is entered into by and between AVEO Pharmaceuticals, Inc., a Delaware corporation, having its principal place of business at 650 East Kendall Street, Cambridge, MA 02142 (the “Company”) and Tuan Ha-Ngoc (the “Employee”) (each, a “Party” and, collectively, the “Parties”).
